These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Novel pharmacologic agents for type 2 diabetes. Uwaifo GI; Ratner RE Endocrinol Metab Clin North Am; 2005 Mar; 34(1):155-97. PubMed ID: 15752927 [TBL] [Abstract][Full Text] [Related]
23. Options for combination therapy in type 2 diabetes: comparison of the ADA/EASD position statement and AACE/ACE algorithm. Bailey T Am J Med; 2013 Sep; 126(9 Suppl 1):S10-20. PubMed ID: 23953074 [TBL] [Abstract][Full Text] [Related]
24. Differential effects of rosiglitazone and metformin on adipose tissue distribution and glucose uptake in type 2 diabetic subjects. Virtanen KA; Hällsten K; Parkkola R; Janatuinen T; Lönnqvist F; Viljanen T; Rönnemaa T; Knuuti J; Huupponen R; Lönnroth P; Nuutila P Diabetes; 2003 Feb; 52(2):283-90. PubMed ID: 12540598 [TBL] [Abstract][Full Text] [Related]
25. The use of insulin secretagogues in the treatment of type 2 diabetes. Luna B; Hughes AT; Feinglos MN Prim Care; 1999 Dec; 26(4):895-915. PubMed ID: 10523467 [TBL] [Abstract][Full Text] [Related]
26. Metformin and pioglitazone: Effectively treating insulin resistance. Staels B Curr Med Res Opin; 2006; 22 Suppl 2():S27-37. PubMed ID: 16914073 [TBL] [Abstract][Full Text] [Related]
28. The Pro12Ala variant at the peroxisome proliferator-activated receptor gamma gene and change in obesity-related traits in the Diabetes Prevention Program. Franks PW; Jablonski KA; Delahanty L; Hanson RL; Kahn SE; Altshuler D; Knowler WC; Florez JC; Diabetologia; 2007 Dec; 50(12):2451-60. PubMed ID: 17898990 [TBL] [Abstract][Full Text] [Related]
29. Potential contribution of metformin to the management of cardiovascular disease risk in patients with abdominal obesity, the metabolic syndrome and type 2 diabetes. Després JP Diabetes Metab; 2003 Sep; 29(4 Pt 2):6S53-61. PubMed ID: 14502101 [TBL] [Abstract][Full Text] [Related]
30. The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes. Freemark M; Bursey D Pediatrics; 2001 Apr; 107(4):E55. PubMed ID: 11335776 [TBL] [Abstract][Full Text] [Related]
31. Recent diabetes issues affecting the primary care clinician. Sando KR; Barboza J; Willis C; Taylor J South Med J; 2011 Jun; 104(6):456-61. PubMed ID: 21886036 [TBL] [Abstract][Full Text] [Related]
33. Harnessing the weight-regulating properties of glucagon-like peptide-1 in the treatment of type 2 diabetes. Sesti G Diabetes Obes Metab; 2009 Dec; 11 Suppl 3():4-10. PubMed ID: 19878256 [TBL] [Abstract][Full Text] [Related]
34. Pharmacologic prevention or delay of type 2 diabetes mellitus. Anderson DC Ann Pharmacother; 2005 Jan; 39(1):102-9. PubMed ID: 15562143 [TBL] [Abstract][Full Text] [Related]
35. Metformin hydrochloride in the treatment of type 2 diabetes mellitus: a clinical review with a focus on dual therapy. Setter SM; Iltz JL; Thams J; Campbell RK Clin Ther; 2003 Dec; 25(12):2991-3026. PubMed ID: 14749143 [TBL] [Abstract][Full Text] [Related]
36. Evaluation of the safety and efficacy of sibutramine, orlistat and metformin in the treatment of obesity. Gokcel A; Gumurdulu Y; Karakose H; Melek Ertorer E; Tanaci N; BascilTutuncu N; Guvener N Diabetes Obes Metab; 2002 Jan; 4(1):49-55. PubMed ID: 11874442 [TBL] [Abstract][Full Text] [Related]
37. Insulin resistance syndrome: options for treatment. Granberry MC; Fonseca VA South Med J; 1999 Jan; 92(1):2-15. PubMed ID: 9932820 [TBL] [Abstract][Full Text] [Related]
38. The management of type 2 diabetes in children and adolescents. Daaboul JJ; Siverstein JH Minerva Pediatr; 2004 Jun; 56(3):255-64. PubMed ID: 15252375 [TBL] [Abstract][Full Text] [Related]
39. What are the pharmacotherapy options for treating prediabetes? Daniele G; Abdul-Ghani M; DeFronzo RA Expert Opin Pharmacother; 2014 Oct; 15(14):2003-18. PubMed ID: 25139488 [TBL] [Abstract][Full Text] [Related]
40. DPP-4 inhibitors and GLP-1 analogues: for whom? Which place for incretins in the management of type 2 diabetic patients? Halimi S Diabetes Metab; 2008 Feb; 34 Suppl 2():S91-5. PubMed ID: 18640591 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]